Human Vaccines & Immunotherapeutics: News July 2022
Year: 2022
Type: article
Abstract: The US Food and Drug Administration (FDA) has granted emergency-use authorization to the adjuvanted protein subunit vaccine NVX-CoV2373 (Novavax) for use in adults. The decision is based on a Phase...
Authors: Ronald Ellis, Adam Weiss
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,175
OpenAlex ID: W4292551993